Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

jective response rate. This global study, conducted by Janssen, was opened in Q1 of 2013 and Janssen plans to enroll 110 patients.

Conference Call and further Corporate UpdatesThe Company will hold a conference call today at 4:30 p.m. EDT. To participate in the conference call, please dial 1-877-407-0778 for domestic callers and 1-201-689-8565 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. To access a replay of the call please dial 1-877-660-6853 domestic callers and 1-201-612-7415 for international callers and use the conference ID number: 413317.  The archived version of the webcast and conference call will be available for 30 days on the Investor Relations section of the company's Web site at http://www.pharmacyclics.com.

About IbrutinibIbrutinib was designed to specifically target and selectively inhibit an enzyme called Bruton tyrosine kinase (BTK). BTK is a key mediator of at least three critical B-cell pro-survival mechanisms occurring in parallel – regulation of apoptosis, cell adhesion, and cell migration and homing.

The effectiveness of ibrutinib alone or in combination with other treatments is being studied in several B-cell malignancies, including chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, Waldenström's macroglobulinemia and multiple myeloma. To date 5 Phase III trials have been initiated with ibrutinib and a total of 28 trials are currently registered on www.clinicaltrials.gov. Janssen Biotech, Inc. and Pharmacyclics entered a collaboration and license agreement in

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014 BRIC Gynecological Devices Market Outlook ... GlobalData,s new report, "BRIC Gynecological Devices Market Outlook ... BRIC Gynecological Devices market. The report provides value, ... and average prices (in US dollars) within market ... (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and ...
(Date:9/17/2014)... 17, 2014 The ambulance equipment ... decade due to the recession, an unstable ... advancements. This BCC Research report analyzes present ... the ambulance and emergency medical services equipment ... hemorrhage control devices, equipment used for burn ...
(Date:9/17/2014)... Pomerantz LLP is investigating claims on behalf ... the "Company") (NASDAQ: PDLI).  Such investors are advised to ... or 888-476-6529, ext. 237. The investigation ... and/or directors have violated Sections 10(b) and 20(a) of ... On September 17, 2014, the Company announced that On ...
Breaking Medicine Technology:BRIC Gynecological Devices Market Outlook to 2020 2BRIC Gynecological Devices Market Outlook to 2020 3Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2
... 2012 Synteract , Inc., a full-service contract ... developing new therapies to combat the growing issue of ... Great Strides fundraising walk to benefit the Cystic ... Rempex (on behalf of Aptalis Pharma) are also working ...
... Ind., May 2, 2012  Hill-Rom Holdings, Inc. (NYSE: ... declared a fiscal year 2012 third quarter dividend of $0.125 ... to shareholders of record as of the close of business ... HOLDINGS, INC. Hill-Rom is a leading worldwide manufacturer ...
Cached Medicine Technology:Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure 2
(Date:9/17/2014)... -- Positive messages about the health benefits of quitting ... new study suggests. Although smokers who think quitting ... the harmful effects of smoking, researchers found smokers who ... from "gain-framed," or positive, messages about how quitting will ... a mix of both types of messages might get ...
(Date:9/17/2014)... [Brown University] As Congress adjourns this month for ... will step over on their way out the chamber ... and Medicare Provider Payment Modernization Act of 2014. In ... , Dr. Eli Adashi recounts what he and other ... bill. The perennial trouble with how Medicare pays doctors ...
(Date:9/17/2014)... New York (PRWEB) September 17, 2014 ... involving the Conserve line of metal-on-metal hip replacements ... underway in U.S. District Court, Northern District of ... updated Case List issued by the U.S. Judicial ... at least 397 product liability claims have been ...
(Date:9/17/2014)... Boston Children’s Museum and From ... concert series, introducing young Museum visitors to musicians ... premier national platform celebrating the stories, talents, and ... young musicians featured will also be showcased on ... is fortunate to partner with the wonderful musicians ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Smart Flour ... Picks by Progressive Grocer, a leading trade magazine targeted ... awarded for originality and flavor, among other attributes. Smart ... an Editor’s Pick in the September print issue of ... website. , The pizza won based on its superior ...
Breaking Medicine News(10 mins):Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2
... step is compromise with House plan, before proposal can become ... gave President Barack Obama a Christmas Eve gift on Thursday ... extend coverage to 31 million uninsured Americans. , Obama said ... that he has sought since his inauguration on Jan. 20. ...
... ... deliver point-of-care drug information on Android devices, , ... Hudson, OH (PRWEB) December 24, 2009 ... healthcare professionals, has released an application for Google Android devices. This latest ...
... ... a distributor of new-to-market nutraceutical and functional food ingredients and ... Purple Stuff, has announced that LuraLean®, AHD’s condensed, water-soluble, dietary ... levels already within the normal range and support regularity, is ...
... , Children,s National Posts Favorite Story on Its Site ... the holiday classic ,Twas the Night before Christmas by ... Center. A video of the classic story being read by ... website, so children and families around the country and world can ...
... , , MINNEAPOLIS, Dec. 23 ... Year,s resolutions for many Minnesotans. As the holiday approaches, ... Minnesota(SM), hopes to motivate them to make a fresh ... most smokers resolve to quit. The new ad acknowledges ...
... , ATLANTA, Dec. 23 At ... of corporate citizenship by fulfilling our mission to offer ... products, unsurpassed quality and service standards, and creative solutions. ... the communities where we do business, we embrace opportunities ...
Cached Medicine News:Health News:Senate Passes Health Reform Package 2Health News:Senate Passes Health Reform Package 3Health News:Senate Passes Health Reform Package 4Health News:Lexi-Comp Now Available for Android™ 2Health News:AHD International & Funktional Beverages, Inc Launch Red Stuff™ with LuraLean 2Health News:'Twas the Night Before Christmas: First Lady Michelle Obama Reads the Holiday Classic 2Health News:Smokers: Resolve to Get the Monkey off Your Back in 2010 2Health News:Smokers: Resolve to Get the Monkey off Your Back in 2010 3Health News:Angelica Extends Helping Hand to Haitian Hospital 2
... line of Surgical Microscope Accessories includes ... lenses, fiber optic cables, and fiberoptic ... Adaptor attaches directly to a Zeiss® ... used to mount the Photo Adaptor ...
Inquire...
... Femoral Compression System consists of a ... FemoStop Femoral Compression System.,Both devices work ... Hemostatic Dressing achieves topical hemostasis by ... while FemoStop Femoral Compression System provides ...
... system. It stores patient chart notes, x-rays, laboratory ... would normally put in a file folder. Your ... write them, file them, find them, determine billing ... lost. They find their way to your house ...
Medicine Products: